Literature DB >> 24063300

Impact of lower pole calculi in patients undergoing retrograde intrarenal surgery.

Francois Martin1, Nicolas Hoarau, Souhil Lebdai, Thomas Pichon, Denis Chautard, Thibaut Culty, Abdel Rahmene Azzouzi, Pierre Bigot.   

Abstract

OBJECTIVE: To assess if the presence of a lower pole stone (LPS) decreases the stone-free (SF) rate following retrograde intrarenal surgery (RIRS). The second purpose was to assess the result of RIRS for LPS and to identify predictors of SF status. PATIENTS AND METHODS: We retrospectively analyzed 205 procedures in 162 patients with renal stones treated by RIRS between January 2010 and January 2013 at a single institute. The SF status was defined as no residual fragments. Independent-sample t-tests and Chi-square tests were used for comparisons of means and proportions, respectively, between patients with or without LPS. Logistic regression models were used to assess prognostic factors influencing SF status in cases of LPS.
RESULTS: LPS were present in 89 (54.9%) patients. There were no differences between patients with or without LPS regarding the mean operative time (p=0.77), the surgeon's experience (p=0.522), the length of hospital stay (p=0.269), and the SF rate (p=0.224). SF status after RIRS in patients with or without LPS was 74.1% and 78% (p=0.224), respectively. In the case of LPS, the presence of multiple stones and a history of percutaneous nephrolithotomy (PCNL) were predictive factors for occurrence of residual fragments in univariate analysis (p=0.037 and p=0.015). In multivariable analysis, only the presence of multiple stones remained as a predictive factor (p=0.027; HR=3.2), whereas a trend was observed when there was a history of PCNL (p=0.07; HR=3).
CONCLUSION: The presence of a LPS does not alter the SF rate of RIRS even in cases of early experience. RIRS for LPS appears to be an effective technique, but special attention should be given to patients with multiple stones and/or a history of PCNL.

Entities:  

Mesh:

Year:  2013        PMID: 24063300     DOI: 10.1089/end.2013.0515

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Retrograde intrarenal surgery for renal stones - Part 2.

Authors:  Özcan Kılıç; Murat Akand; Ben Van Cleynenbreugel
Journal:  Turk J Urol       Date:  2017-08-01

2.  Retrograde intrarenal surgery with combined spinal-epidural vs general anesthesia: a prospective randomized controlled trial.

Authors:  Guohua Zeng; Zhijian Zhao; Fengquan Yang; Wen Zhong; Wenqi Wu; Wenzhong Chen
Journal:  J Endourol       Date:  2014-12-15       Impact factor: 2.942

3.  Prediction of stone-free status after single-session retrograde intrarenal surgery for renal stones.

Authors:  Şenol Tonyalı; Mehmet Yılmaz; Mustafa Karaaslan; Cavit Ceylan; Levent Işıkay
Journal:  Turk J Urol       Date:  2018-11

Review 4.  Flexible ureteroscopy: Technological advancements, current indications and outcomes in the treatment of urolithiasis.

Authors:  Husain Alenezi; John D Denstedt
Journal:  Asian J Urol       Date:  2015-06-23

Review 5.  A comprehensive literature-based equation to compare cost-effectiveness of a flexible ureteroscopy program with single-use versus reusable devices.

Authors:  Giovanni S Marchini; Fábio C Torricelli; Carlos A Batagello; Manoj Monga; Fábio C Vicentini; Alexandre Danilovic; Miguel Srougi; William C Nahas; Eduardo Mazzucchi
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

6.  Role of pelvicalyceal anatomy in the outcomes of retrograde intrarenal surgery (RIRS) for lower pole stones: outcomes with a systematic review of literature.

Authors:  Sulaiman Sadaf Karim; Luke Hanna; Robert Geraghty; Bhaskar K Somani
Journal:  Urolithiasis       Date:  2019-08-01       Impact factor: 3.436

Review 7.  Retrograde intrarenal surgery: An expanding role in treatment of urolithiasis.

Authors:  María Rodríguez-Monsalve Herrero; Steeve Doizi; Etienne Xavier Keller; Vincent De Coninck; Olivier Traxer
Journal:  Asian J Urol       Date:  2018-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.